MXPA04002400A - Sales de acidos salicilicos, metodos para su preparacion y su uso como medicamentos. - Google Patents

Sales de acidos salicilicos, metodos para su preparacion y su uso como medicamentos.

Info

Publication number
MXPA04002400A
MXPA04002400A MXPA04002400A MXPA04002400A MXPA04002400A MX PA04002400 A MXPA04002400 A MX PA04002400A MX PA04002400 A MXPA04002400 A MX PA04002400A MX PA04002400 A MXPA04002400 A MX PA04002400A MX PA04002400 A MXPA04002400 A MX PA04002400A
Authority
MX
Mexico
Prior art keywords
medicaments
production
methods
salicylic acid
acid salts
Prior art date
Application number
MXPA04002400A
Other languages
English (en)
Inventor
Soyka Rainer
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2001145438 external-priority patent/DE10145438A1/de
Priority claimed from DE2002116125 external-priority patent/DE10216125A1/de
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of MXPA04002400A publication Critical patent/MXPA04002400A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/08Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to an acyclic carbon atom
    • C07C217/10Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical containing six-membered aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/468-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06Antiabortive agents; Labour repressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Abstract

La presente invencion se refiere a nuevas sales de acido salicilico substituidas de salmeterol asi como tambien a metodos para la produccion y uso de las mismas como medicamentos.
MXPA04002400A 2001-09-14 2002-09-06 Sales de acidos salicilicos, metodos para su preparacion y su uso como medicamentos. MXPA04002400A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE2001145438 DE10145438A1 (de) 2001-09-14 2001-09-14 Neue Arzneimittel zur Inhalation
DE2002116125 DE10216125A1 (de) 2002-04-12 2002-04-12 Salicylsäuresalze, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
PCT/EP2002/009975 WO2003024440A1 (de) 2001-09-14 2002-09-06 Salicylsäuresalze, verfahren zu deren herstellung und deren verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
MXPA04002400A true MXPA04002400A (es) 2004-05-31

Family

ID=26010150

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04002400A MXPA04002400A (es) 2001-09-14 2002-09-06 Sales de acidos salicilicos, metodos para su preparacion y su uso como medicamentos.

Country Status (7)

Country Link
EP (1) EP1429751A1 (es)
JP (1) JP4199114B2 (es)
CA (1) CA2460440A1 (es)
MX (1) MXPA04002400A (es)
PE (1) PE20030444A1 (es)
UY (1) UY27443A1 (es)
WO (1) WO2003024440A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012277403A1 (en) * 2011-06-30 2014-01-30 Ranbaxy Laboratories Limited Novel salts of sitagliptin

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW6584A1 (en) * 1983-04-18 1985-04-17 Glaxo Group Ltd Phenethanolamine derivatives

Also Published As

Publication number Publication date
CA2460440A1 (en) 2003-03-27
PE20030444A1 (es) 2003-07-03
JP2005504798A (ja) 2005-02-17
JP4199114B2 (ja) 2008-12-17
UY27443A1 (es) 2003-04-30
WO2003024440A1 (de) 2003-03-27
EP1429751A1 (de) 2004-06-23

Similar Documents

Publication Publication Date Title
NL300933I2 (nl) Letermovir
AP1614A (en) New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents.
MY134892A (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use
MXPA03000510A (es) Sales estables de acido o-acetilsalicilico con aminoacidos basicos.
TW200505837A (en) Novel compounds
YU91002A (sh) Derivati acilfenil-karbamida, postupak za njihovu proizvodnju i njihova primena kao leka
MXPA05013752A (es) Procedimiento e intermediarios para la preparacion de (1r,2s,5s)-6,6-dimetil-3-azabiciclo[3,1,0]exan-2-carboxilatos o sales de los mismos.
SE0301009D0 (sv) Novel compounds
HK1087022A1 (en) Dpp-iv inhibitors
PL1758852T3 (pl) Podstawione związki cyklopentenu
YU7804A (sh) Stabilni polimorf flibanserina,postupak za njegovo dobijanje u industrijskim razmerama i njegova primena za pripremanje lekova
BG111461A (en) TECHNICAL METHOD FOR OBTAINING TROPENOL
TNSN04250A1 (en) Diphenyl azetidinones substituted by acidic groups, method for their production, medicaments containing said compounds and use thereof.
IL165790A0 (en) Cationically substituted diphenyl azetidinones method for their production medicaments containing said compounds and use thereof
ATE291024T1 (de) Neue 4-aminofuropyrimidine und ihre verwendung
UA86399C2 (ru) Применение 2,5 дигидроксибензолсульфоновой кислоты для изготовления лекарства, которые применяют для лечения болезней, зависимых от ангиогенеза
PL371127A1 (en) 6-aminomorphinane derivatives, method for the production and use thereof
WO2002030870A3 (de) Substituierte c-cyclohexylmethylamin-derivate
MXPA04000446A (es) 4-aminociclohexanoles sustituidos.
WO2001049654A3 (de) Substituierte aminomethyl-phenyl-cyclohexanderivate
MXPA04004090A (es) Compuestos substituidos de 1h-quinolin-2-ona.
WO2004022542A3 (de) Substituierte 1,2,3,4-tetrahydrochinolinderivate
MXPA04002400A (es) Sales de acidos salicilicos, metodos para su preparacion y su uso como medicamentos.
ATE242763T1 (de) Methoximinophenylessigsäureamide
CA2425368A1 (en) New sulphoxybenzamides

Legal Events

Date Code Title Description
FG Grant or registration